Prosecution Insights
Last updated: October 02, 2026
Application No. 17/783,123

CURABLE PERFLUOROPOLYETHER ADHESIVE COMPOSITION, AND ADHESIVE AND ADHESIVE TAPE INCLUDING CURED PRODUCT THEREOF

Final Rejection §103
Filed
Jun 07, 2022
Priority
Dec 17, 2019 — JP 2019-227304 +1 more
Examiner
BLEDSOE, JOSHUA CALEB
Art Unit
1762
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Shin-Etsu Chemical Co., Ltd.
OA Round
4 (Final)
44%
Grant Probability
Moderate
5-6
OA Rounds
0m
Est. Remaining
97%
With Interview

Examiner Intelligence

Grants 44% of resolved cases
44%
Career Allowance Rate
44 granted / 99 resolved
-20.6% vs TC avg
Strong +53% interview lift
Without
With
+52.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
55 currently pending
Career history
173
Total Applications
across all art units

Statute-Specific Performance

§101
0.8%
-39.2% vs TC avg
§103
62.0%
+22.0% vs TC avg
§102
16.1%
-23.9% vs TC avg
§112
16.4%
-23.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 99 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claims 12, 15, 26, 28, and 30, are rejected under 35 U.S.C. 103 as being unpatentable over Azechi (JP 2012122024 A, hereinafter referring to both the original Japanese version and the ESPACENET English translation) in view of Koshikawa-602 (US 2005/0090602 A1). Regarding claim 12, Azechi teaches an adhesive sheet suitable for use as a masking material for painting applications ([0001]), comprising an adhesive layer ([0002]) made from a fluororesin gel ([0012]), comprising: 30 to 90 parts by mass of a linear perfluoropolyether compound having at least two alkenyl groups in one molecule and a perfluoropolyether structure in the main chain ([0012]), including hexafluoropropylene oxide groups (which read on the claimed “repeating unit represented by -CaF2aO-“ because hexafluoropropylene oxide groups fall within this representative structure when a is 3), which reads on the claimed component “(A)”. An amount of any single compound can be mathematically normalized to 100 parts by mass. Thus, any amount of this compound reads on the claimed “100 parts,” as long as the masses of the remaining components are similarly normalized such that the relative amounts of each compound are proportionally similar to the taught ranges. An effective curing amount of an organosilicon compound having at least two hydrogen atoms bonded to silicon atoms in one molecule ([0012]), which reads on the claimed component “(B)” A catalytic amount of a hydrosilylation reaction catalyst ([0012]), which reads on the claimed component “(C)” Regarding the newly-added limitation requiring that the composition be free from a fluoromonoalkenyl compound having one alkenyl group per molecule and having a perfluoroether structure or perfluoropolyether structure in a main chain, Azechi differs from claim 12 because it teaches the incorporation of a pefluoromonoalkenyl compound having one alkenyl group in one molecule and a perfluoroether structure in the main chain ([0012]). In the same field of endeavor, Koshikawa-602 teaches an adhesive composition containing a linear perfluoropolyether, a fluorinated organohydrogensiloxane, and a platinum catalyst (Abstract), and further teaches the incorporation of additional components including plasticizers, viscosity modifiers, and flexibilizers, of which polyfluoromonoalkenyl compounds are a suitable option ([0092]). In addition to the polyfluoromonoalkenyl compounds, Koshikawa-602 additionally teaches the optional use of linear polyfluoro compounds, which do not have one alkenyl group in one molecule ([0092], [0094], and [0098]). It is prima facie obvious to substitute equivalents known in the art as suitable for the same purpose (see MPEP 2144.06). Therefore, it would have been obvious to one having ordinary skill in the art at the time of filing to substitute the polyfluoromonoalkenyl compound of Azechi with a linear polyfluoro compound of Koshikawa-602 (which does not contain one alkenyl group in one molecule and which therefore does not fall under the purview of the excluded compounds), as Koshikawa-602 recognizes said linear polyfluoro compounds as suitable alternatives thereto. In so doing, the formulation of Azechi as modified does not contain a fluoromonoalkenyl compound having one akenyl group per molecule, and therefore meets all of the compositional limitations of the claimed composition. Azechi teaches that the composition preferably has an adhesive strength ranging from 0.5 to 5 N/25 mm ([0034]), which does not overlap the claimed range of “less than 0.5 N/25 mm. Nevertheless, Azechi teaches a composition whose adhesive strength lies very close to the upper limit of the claimed range. In cases where the claimed ranges or amounts do not overlap with the prior art but are merely close, a prima facie case of obviousness exists (See MPEP 2144.05.I.). Furthermore, the composition of Azechi as described above meets all of the compositional limitations of the claimed composition. Products of identical chemical compositions cannot have mutually exclusive properties. Where the claimed and prior art products are identical or substantially identical in structure or composition, a prima facie case of obviousness has been established. See MPEP 2112.01. The claimed adhesion characteristic will therefore necessarily be present in Azechi as applied above. Regarding the amendment to claim 12 which now requires that the composition “consists essentially of” the listed ingredients, this transitional phrase limits the scope of a claim to the specified materials or steps "and those that do not materially affect the basic and novel characteristic(s)" of the claimed invention (see MPEP 2111.03). In this case, the specification refers to many subjective measures of characteristics such as "excellent" heat resistance, weatherability, water repellency, etc., and includes one objective characteristic, adhesion strength (less than 0.5 N/25 mm). The subjective characteristics are somewhat dubious in terms of being "basic and novel characteristics" because the term "excellent" is subjective and because the Specification does not specify what qualifies as "excellent." Moreover, the excellent chemical and solvent resistance and necessary adhesion characteristics are indicated as arising from the presence of claimed component (A) and (D) ([0018] and [0016]). Spec also states that (B) and (C) are responsible for curing capability ([0133]). The specification makes no mention that the incorporation of plasticizers, viscosity modifiers, and/or flexibilizers would inhibit these characteristics. To the contrary, the specification contemplates the incorporation of other additives (e.g., [0095]), indicating that the mere presence of other components does not necessarily imply the destruction of the basic and novel characteristics of the claimed composition. Therefore, the incorporation of a linear polyfluoropolyether compounds of Azechi as modified by Koshikawa would not materially affect the basic and novel characteristics of the claimed invention, and thus are included in the claimed composition. Regarding claim 15, Azechi teaches that the preferred linear perfluoropolyether compounds are those which are exactly the same as the claimed structures (see [0014] of both the translated and original Japanese versions of Azechi). Regarding claim 26, Azechi teaches all of the limitations of claim 12 as described above. Azechi differs from claim 26 because it is silent with regard to the claimed volume resistivities. Nevertheless, Azechi as applied above results in a composition that is structurally identical to the claimed “adhesive composition,” which contains all of the same components in the same compositional amounts. Products of identical chemical compositions cannot have mutually exclusive properties. Where the claimed and prior art products are identical or substantially identical in structure or composition, a prima facie case of obviousness has been established. See MPEP 2112.01. The claimed volume resistivities will therefore necessarily be present in Azechi as applied to claim 12, above. Regarding claim 28, Azechi teaches that the inventive formulation is used as an adhesive layer to be used in an adhesive sheet for paint applications ([0001]-[0002] and [0012]), which reads on the claimed “adhesive.” Regarding claim 30, Azechi teaches that the inventive formulation is used as an adhesive layer to be used in an adhesive sheet for paint applications ([0001]-[0002] and [0012]), which reads on the claimed “tape” because the adhesive of Azechi is deposited onto a sheet of plastic (e.g., [0139]), and the overall invention is used as an adhesive sheet (i.e., a tape). Response to Arguments Applicant's arguments filed April 20, 2026 have been fully considered but they are not persuasive. Applicant argues that Azechi contains a perfluoromonoalkenyl compound having one alkenyl group per molecule and having a perfluoropolyether structure in a main chain.” However, as described above, it would have been obvious to one having ordinary skill in the art at the time of filing to substitute this component for the linear polyfluoro compound of Koshikawa-602 (which does not contain one alkenyl group in one molecule and which therefore does not fall under the purview of the excluded compounds), as Koshikawa-602 recognizes said linear polyfluoro compounds as suitable alternatives thereto. Furthermore, in response to applicant's arguments against the references individually, one cannot show nonobviousness by attacking references individually where the rejections are based on combinations of references. See In re Keller, 642 F.2d 413, 208 USPQ 871 (CCPA 1981); In re Merck & Co., 800 F.2d 1091, 231 USPQ 375 (Fed. Cir. 1986). Applicant next argues that the use of “consisting essentially of” phrasing excludes the linear polyfluoro compounds of Koshikawa-602. However, as described above, the incorporation of a linear polyfluoropolyether compounds of Koshikawa-602 into Azechi would not materially affect the basic and novel characteristics of the composition’s basic and material characteristics, and thus are included in the claimed composition. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOSHUA CALEB BLEDSOE whose telephone number is (703)756-5376. The examiner can normally be reached Monday-Friday 8:00 a.m. - 5:00 p.m. EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Jones can be reached at 571-270-7733. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOSHUA CALEB BLEDSOE/Examiner, Art Unit 1762 /ROBERT S JONES JR/Supervisory Patent Examiner, Art Unit 1762
Read full office action

Prosecution Timeline

Show 2 earlier events
Jun 04, 2025
Response Filed
Aug 11, 2025
Final Rejection mailed — §103
Nov 07, 2025
Response after Non-Final Action
Dec 11, 2025
Request for Continued Examination
Dec 17, 2025
Response after Non-Final Action
Jan 21, 2026
Non-Final Rejection mailed — §103
Apr 20, 2026
Response Filed
Aug 06, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12742039
METHOD FOR PREPARING GLUTARYL-BRIDGED BIS-BIOGENIC GUANIDINE CHELATE AND METHOD FOR PREPARING POLYBUTYLENE SUCCINATE
2y 6m to grant Granted Sep 22, 2026
Patent 12735571
SILICONE FORMULATION WITH HIGH TEMPERATURE STABILITY AND CLARITY
4y 2m to grant Granted Sep 15, 2026
Patent 12735526
POLYURETHANE-REACTIVE SYSTEM FOR PULTRUSION
3y 8m to grant Granted Sep 15, 2026
Patent 12735522
RESIN COMPOSITION AND ARTICLE MADE THEREFROM
3y 2m to grant Granted Sep 15, 2026
Patent 12729286
CRYSTAL NUCLEATING AGENT COMPOSITION FOR POLYOLEFIN RESIN, AND POLYOLEFIN RESIN COMPOSITION INCLUDING SAID CRYSTAL NUCLEATING AGENT COMPOSITION
4y 0m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
44%
Grant Probability
97%
With Interview (+52.7%)
3y 5m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 99 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month